VolitionRx Limited (VNRX)

Overview

VolitionRx Limited is a pioneering multi-national epigenetics company focused on the advancement of blood tests designed to diagnose a variety of cancers and other diseases around the globe. With its foundations in Austin, Texas, the company has made significant strides in the healthcare industry through its innovative approach to early detection and diagnosis. Leveraging their proprietary Nucleosomics technology platform, VolitionRx is at the forefront of developing non-invasive diagnostic solutions, aiming to revolutionize how diseases, especially cancer, are detected and managed worldwide.

Products and Services

Nu.Q - This innovative product line is developed to detect cancer through blood tests, offering a non-invasive, straightforward approach to cancer diagnosis. By facilitating early detection, these tests are crucial in improving patient outcomes and optimizing treatment strategies.

Nu.Q Nets - Aimed at monitoring the immune system, Nu.Q Nets are designed to provide insights into the body's defense mechanism. This is particularly beneficial in understanding and managing autoimmune diseases, cancer progression, and the effectiveness of certain treatments by providing a detailed profile of the immune system's condition.

Nu.Q Vet - Focusing on veterinary applications, the Nu.Q Vet cancer screening test is a testament to VolitionRx's commitment to comprehensive healthcare. This product extends the benefits of early cancer detection to the animal population, offering veterinarians a valuable tool in diagnosing and treating pets and livestock effectively.

Nu.Q Capture - This solution is crafted for capturing and concentrating samples to enhance the accuracy of diagnosis. By improving the quality of the sample, Nu.Q Capture aims to facilitate a more precise and definitive diagnosis, thereby reducing uncertainties and increasing the reliability of test results.

Nu.Q Discover - Nu.Q Discover offers a solution for profiling nucleosomes, which can be pivotal in understanding various diseases at a molecular level. This product supports research and development activities, driving forward the discovery of new insights and potentially leading to breakthroughs in disease diagnosis and treatment strategies.